Should bone biopsy be the standard for suspected osteomyelitis in patients with pressure ulcers?

Amy Ferris
DOI: https://doi.org/10.12968/jowc.2024.33.3.202
2024-03-08
Journal of Wound Care
Abstract:Osteomyelitis is a recognised complication of category 4 pressure ulcers (PUs), and the prevalence of PUs is increasing. The diagnostic criteria for osteomyelitis in the context of PUs is a topic of much debate, and many believe that tissue diagnosis from a bone biopsy should be considered the gold standard. However, in this review we discuss the inconclusive evidence base for both microbiological and histological diagnoses, suggesting that bone biopsy has a limited role in patients' diagnosis and management. We also discuss how, for patients in whom surgical wound coverage is not appropriate, the benefit of antimicrobial therapy for osteomyelitis is unclear and, by extension, the role of biopsy in this context is questionable. As our patient population becomes frailer, it is more important than ever to understand the evidence base underlying investigations such as bone biopsy, to critically consider whether they are likely to change clinical management and whether their benefit outweighs their risks. Declaration of interest: The author has no conflicts of interest to declare.
dermatology
What problem does this paper attempt to address?